Loading clinical trials...
Loading clinical trials...
Phase II, Randomized Trial of Gemcitabine and Docetaxel With or Without Bevacizumab (Onbevzi) for Previously Treated Soft Tissue Sarcoma
Conditions
Interventions
Bev + Gem + Doc
Gem + Doc
Start Date
June 1, 2026
Primary Completion Date
November 30, 2028
Completion Date
November 30, 2028
Last Updated
April 23, 2026
Lead Sponsor
Yonsei University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions